Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundbeck’s sales increased by 15% (+11% at constant exchange rates) to DKK 5 billion in the first quarter of 2023

Key highlights Lundbeck’s sales increased by 15% (+11% CER[1]) to DKK 5,044 million, with all regions growing and the U.S. and Europe contributing strongly · United States: DKK 2,337 million (+22%; +16% CER) · International Markets: DKK 1,499 million (+3%; +3% CER) · Europe: DKK 1,174 million (+15%; +14% CER) The growth of Lundbeck’s strategic brands grew further with an increase of 23% (+19% CER), reaching DKK 3,273 million, representing 65% of total revenue · Brintellix[®]/Trintellix[®]: DKK 1,077 million (+9%; +7% CER) · Rexulti[®]/Rxulti[®]: DKK 1,060 million (

HKScan’s profitability improved, but January-March EBIT slightly negative

HKScan Corporation, January-March Interim Report, 10 May 2023 at 8.30 a.m. EETHKScan’s Interim Report 1 January – 31 March 2023 January-March 2023  · HKScan’s net sales from continuing operations increased by 15.6 per cent to EUR 457.6 (395.9) million. During the review period, sales prices were significantly higher than in the comparison period as higher costs due to strong inflation had been passed on to sales prices during 2022. · The Group’s EBIT from continuing operations totalled EUR -0.1 (-4.4) million.  · The Group’s comparable EBIT from continuing operations was EUR -

Saga Pure: First quarter 2023 financial results

(Oslo, 10 May 2023) Saga Pure ASA (Saga Pure, OSE: SAGA) reported a net loss in the first quarter 2023 of NOK 81.7 million (Q1 2022: Profit NOK 53.6 million), corresponding to a return on equity of minus 8.2 percent year to date. The negative result in the first quarter is mainly driven by the share price development in legacy investment Horisont Energi AS. Saga Pure continues to implement the expanded investment mandate with a focus on capital discipline and selective investments.“The reported financial results in the first quarter of 2023 reflect the negative share price development in

Terveystalo Capital Markets Day 2023

Terveystalo hosts its Capital Markets Day today, 10 May 2023 in Helsinki at 10:00-14:30 EEST. The event will offer an update on Terveystalo’s current operating environment and strategy with the new operating model, as well as an update on the progress of the 2-year profit improvement program. The day will include presentations by Ville Iho, President, and CEO, Juuso Pajunen, CFO, and other management team members. The presentation materials will be available at the beginning of the event at: https://www.terveystalo.com/en/company/investors/capital-markets-day-2023.All the

Skanska signs 20,300 square meter lease agreement in the Centrum Poludnie office complex in Wroclaw, Poland

Skanska has signed a 10-year lease agreement with the American bank BNY Mellon for approximately 20,300 square meters and in addition 191 parking lots in the second phase of Centrum Poludnie office complex in Wroclaw, Poland. With this contract, all office space is leased, with the remaining space dedicated to amenity and retail uses, such as a kindergarten. In total, 93 percent of the building is now leased.BNY Mellon serves capital markets globally by providing comprehensive solutions for clients to manage and service their financial assets throughout the investment life cycle. Wroclaw

Notice to annual general meeting in Readly International AB (publ)

The shareholders are hereby called to the annual general meeting of Readly International AB (publ), 556912-9553, (the “Company”), to be held on Tuesday 13 June 2023 at 14:00 (CEST), at the Company's premises at Kungsgatan 17 in Stockholm. Entry and registration begin at 13:30 (CEST).The board of directors has decided, pursuant to the Company’s articles of association, that shareholders shall have the right to exercise their voting rights by postal voting. Shareholders may therefore choose to exercise their voting rights at the annual general meeting by attending in person, through a proxy

Wihlborgs starts the transformation of the historic Malmö Börshus

Malmö Börshus (Börshuset 1) is more than just a historic building and a symbol for trade and commerce in the city – it is also a central location through which some 50,000 people pass daily. Now Wihlborgs is starting a transformation that, after an extensive renovation, will showcase its character and history and at the same time open it up to become a more dynamic city space.Renovation of the facade and the interior are both starting in autumn 2023. The aim is to upgrade to a more modern and energy efficient standard, and to reinstate the original appearance of the Börshus, while also

Archer Limited: Strong first quarter financial performance

Hamilton, Bermuda (May 10, 2023) First Quarter 2023 Highlights · Revenue of $267 million, up 22% from the same quarter last year · Strong EBITDA of $25.2 million, up 55% from the same quarter last year · Strong cash management contributed to reduced NIBD · Integrated the P&A specialist Romar-Abrado during the quarter · Completed the acquisition of Baker Hughes’ UK coil tubing and pumping business · Completed the refinancing in April On the strong first quarter, Dag Skindlo, CEO of Archer, comments: “I am pleased to report strong financial results in the first

STOREBRAND ASA: Results for the 1st Quarter 2023

· Cash equivalent earnings[1] of NOK 757m and IFRS profit before amortisation and tax of NOK 1,157m in the quarter · Solvency II ratio 179% · All-time high assets under management amounting to NOK 1,111bn, up 9% in the quarter supported by NOK 18bn net inflow Storebrand continues to deliver very strong growth in all business areas – occupational pensions, asset management, and in the Norwegian retail market – despite another quarter with market turbulence where inflation remains high and central banks continue to raise rates. I'm proud to see that we have reached an all-time high

Sitowise's Interim Report January - March 2023: Strong quarter in a challenging market environment

Sitowise Group Plc, Interim Report, 1 January - 31 March 2023, 10 May 2023 at 8:30 am EEST This release is a summary of Sitowise Group’s financial statements release January–December 2022. The complete financial statements release is attached, and also available on the company’s website at www.sitowise.com/investors/reports-and-presentations January – March in brief · Net sales increased by 14% to EUR 56.0 (49.2) million. · Organic net sales grew by 4% (7%). · Adjusted EBITA was EUR 6.6 (5.2) million, or 11.8% (10.6%) of net sales. · Operating profit totaled EUR 5.5 (2.9)

Shaping next generation material handling for a smarter, safer and better world: Konecranes announces new financial targets

KONECRANES PLC INSIDE INFORMATION MAY 10, 2023 8:30 AM EEST   Shaping next generation material handling for a smarter, safer and better world: Konecranes announces new financial targets   Konecranes announces its refreshed purpose, ambition and financial targets for the coming years ahead of its Capital Markets Day which will be held today, May 10.   “The world is facing an increasingly acute challenge to provide materials and goods that are essential for people while preserving scarce resources and limiting emissions. Businesses have a central role to play in solving this

Eevia Health Plc exhibiting at a key tradeshow – Vitafoods 2023 in Geneva

Eevia Health Plc (”Eevia” or ”The Company”) is promoting its products and value proposition by exhibiting at Vitafoods 2023, a key nutraceutical tradeshow in Geneva, Switzerland between 9 – 11 May 2023Eevia is represented by its sales team and a stand at the annual Vitafoods tradeshow , which is held in Geneva in the second week of May every year. Vitafoods is a key event in the global nutraceutical industry, attracting over 15,000 industry experts from over 130 countries every year. The show has built its leading position since 1997 by maintaining

BlueNord Announce First Quarter 2023 Results

Oslo, 10 May 2023: BlueNord ASA ("BlueNord" or the "Company") today published its first quarter 2023 results. The first quarter of the year delivered excellent operational performance and strong cash generative financial results.  Highlights: · First quarter net hydrocarbon production of 26.6 mboepd, above quarterly guidance · Strong underlying reservoir performance where natural decline is mitigated by high level of well activities · Revenues of USD 221 million compared to USD 179 million in same quarter in 2022 · EBITDA in Q1 of USD 122 million, versus USD 107 million in

Investor supports Sobi’s tender offer for CTI BioPharma and undertakes to subscribe for its pro rata share in Sobi’s rights issue

Sobi has today communicated its offer to acquire CTI BioPharma (CTI), a US listed company within hematology, for USD 9.10 per share, equivalent to an enterprise value of USD 1.7bn and to carry out a rights issue with preferential rights for existing shareholders to partially finance the acquisition. Investor AB, Sobi’s largest owner, with an ownership of 34.7 per cent of the capital and votes, supports the bid and has undertaken to subscribe for its pro rata share in the rights issue corresponding to SEK 2.9bn. “Investor was instrumental in the creation of Sobi close to 15 years ago.

Interim Report 3 months - 1 January-31 March 2023

FIRST QUARTER (1 JAN-31 MAR 2023) · Net sales declined by 12 percent to MSEK 1,505 (1,716), of which currency-adjusted sales declined 15 percent. · Operating profit before depreciation and amortisation (EBITDA) excluding non-recurring items of MSEK 0 (-11) amounted to MSEK 138 (168) 1). · Operating profit amounted to MSEK 70 (86) 1), corresponding to an operating margin of 4.7 percent (5.0). · Profit after financial items totalled MSEK 57 (80). · Profit after tax amounted to MSEK 41 (57). · Earnings per share before and after dilution totalled SEK 0.15 (0.25). 2) ·

Camurus’ Interim Report January-March 2023

“A strong quarter with solid organic growth, both top and bottom line” Summary first quarter 2023 January – March · Total revenues amounted to SEK 284 (220) million, an increase of 29% (24% at CER[1]), whereof product sales were SEK 282 (202) million, an increase of 40% (35% at CER[1]) · Revenue and product sales increased 6% compared to previous quarter · Operating result was SEK 74 (5) million, an increase of SEK 69 million · Cash position at the end of the quarter was SEK 586 (400) million, an increase of SEK 186 million (47%) · Number of patients treated with

Sobi to acquire CTI BioPharma Corp. enhancing Sobi’s position in rare haematology

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF OR THE SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION. Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced that it has entered into an agreement and plan of merger with CTI BioPharma Corp. (CTI) under which Sobi has agreed to acquire CTI, a biopharmaceutical company focused on blood related cancers and

Everfuel – Q1 2023: Strengthened European hydrogen position

Herning, 10 May 2023 – Everfuel A/S today published its first quarter 2023 financial results. Key events · Launch of JV with Hy24 for EUR 200 million of equity investment for accelerated development of green hydrogen infrastructure in the Nordics · Successfully completed EUR 25 million private placement · HySynergy Phase 1 progressing towards mechanical and electrical completion in late Q2 2023, ramp-up of commercial production subject to establishment of best-practice for safe and efficient operations, facility organisation and permitting · Signed agreement for the First

Multiconsult first quarter 2023 – best quarter ever

Multiconsult ASA (OSE: MULTI)The positive trend and strong market development continues, and Multiconsult delivered the best quarter ever. Multiconsult’s first quarter EBITA was NOK 216.3 million, a margin of 16.5 per cent. There was high activity in most segments, and the result was positively impacted by higher billing rates and increased capacity. Net operating revenues grew by 15.1 per cent year-on-year to NOK 1 310.2 million, while the organic growth was 12.1 per cent y-o-y. The result from the segment LINK Arkitektur has improved compared to the same quarter last year. For the second

ABS Explores Near-Shore Green Hydrogen Production in Korea

MOU Signed by ABS and Leading Industry Players (MUNICH) ABS joined Korean industry leaders in the signing of a memorandum of understanding (MOU) to produce a feasibility study for a near-shore floating platform of green hydrogen production and liquefaction. ABS joins the Korea Institute of Energy Technology (KENTECH); HD Korea Shipbuilding and Offshore Engineering (HD KSOE), part of HD Hyundai Group; Linde Korea; and Linde PLC in the MOU. The study is the latest in ABS’ pioneering work to support green hydrogen production, which includes an approval in principle (AIP) for HD

#23-159 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Nordea Bank Abp: Repurchase of own shares on 09.05.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares09.05.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 09.05.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |148,601|9.62 |1,428,932.

Salmon Evolution ASA: Cancellation of the potential subsequent offering

Reference is made to the stock exchange announcement published by Salmon Evolution ASA ("Company") on 19 April 2023 regarding the successful placing of a private placement of 68,181,818 shares at a subscription price of NOK 7.7 (the “Subscription Price”) in the Company to raise gross proceeds of NOK 525 million (the "Private Placement") and a potential subsequent share offering of up to 6,500,000 new shares at the Subscription Price (the "Subsequent Offering"). The Company expressed that any such potential Subsequent Offering was conditional on, inter alia, prevailing market price of the

Trading of own shares as part of employee's savings scheme

SpareBank 1 SR-Bank ASA has on 9 May 2023 purchased 25 334 own shares at an average price of 119.4546. Total holdings of own shares after the purchase is 123 435 shares. The shares were acquired as part of SpareBank 1 SR-Bank's savings scheme for employees. For more information about the saving scheme reference is made to the stock exchange notice dated 19 December 2022, and the stock exchange notice dated 14 April 2023.

There are no items matching the current filter
There are no more items matching the current filter
Back to top